FOLH1 and metastatic neoplasm: Notably, a subset of patients (15 cases) presented with metastases across all three sites (bone, lymph nodes, and soft tissue), underscoring the comprehensive diagnostic capability of PSMA PET/CT in identifying multifocal metastatic disease.